Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus - 0 views
-
exenatide dose-dependently reduced postprandial plasma glucose excursion by insulinotropism
-
suppression of plasma glucagon, and slowing of gastric emptying.